Leuprorelin acetate
National NHS prescribing (Prescription Cost Analysis) · Sex hormones and hormone antagonists in malignant disease
Leuprorelin acetate was ranked 392nd of 1,794 medicines by items in March 2026, with 21,452 items, up 0.9% on a year earlier.
21,452items
Dispensed in March 2026
NHSBSA Prescription Cost Analysis
£4,217,129
Net ingredient cost · March 2026
NHSBSA PCA
259,352items
Dispensed in the last 12 months
NHSBSA PCA
Figure 1. Leuprorelin acetate: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to March 2026
Embed this chart
Top presentations, March 2026
The individual products dispensed under Leuprorelin acetate, by items this month.
| Presentation | Items | Net ingredient cost |
|---|---|---|
| Prostap 3 DCS 11.25mg pdr and solvent for prolonged-rel inj | 16,878 | £3,828,888 |
| Prostap SR DCS 3.75mg pdr and solvent for prolonged-rel inj | 4,314 | £334,818 |
| Staladex 11.25mg implant pre-filled syringes | 258 | £53,148 |
| Prostap 3 Depot 11.25mg inj vials | 1 | £215 |
| Prostap PD DCS 1.88mg pdr and solvent for prolonged-rel inj | 1 | £60 |
Compare Leuprorelin acetate with
Other medicines in the same BNF section, by prescribing volume.